Reporting owner · Q3 2026 · CIK 1997584

Lechleider Robert: insider trades.

Lechleider Robert reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($1.2M), across 1 company.

Transactions
5
Purchases (P)
0
Sales (S)
3
Companies
1
Name as filed
Lechleider Robert

Companies

CompanyRelationshipTransactions
Immunome Inc. (IMNM)Officer · Chief Medical Officer5

Transactions

5 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-07-23Immunome Inc.A54,000$069,805Form 4
2026-07-02Immunome Inc.M55,000$8.7370,805Form 4
2026-07-02Immunome Inc.S16,072$23.4415,805Form 4
2026-07-02Immunome Inc.S16,214$22.7631,877Form 4
2026-07-02Immunome Inc.S22,714$21.9548,091Form 4

Questions

What stock did Lechleider Robert buy or sell?

Lechleider Robert reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($1.2M), across 1 company.

Is Lechleider Robert the same person as other filers with this name?

This page covers SEC CIK 1997584 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/lechleider-robert-1997584.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.